In the description, it is mentioned that CAR-T is recently approved. Can I please ask when this was approved in the US and Europe and where I can find the sources for this? Love this video- Thank you so much!
Hello! thank you for your feedback on this video 😊 there are two CAR-T approved drugs, idecabtagene vicleucel in US and Europe and cilta-cel that was approved by the US Food and Drug Administration (FDA) a couple of days ago. Please, find below some information about these drugs: • Idecabtagene vicleucel: www.mpeurope.org/2021/03/31/the-u-s-food-and-drug-administration-fda-approves-the-first-anti-bcma-car-t-cell-therapy-for-myeloma-idecabtagene-vicleucel-abecma • Cilta-cel: www.mpeurope.org/2022/03/02/fda-approves-cilta-cel-for-relapsed-or-refractory-myeloma/ Drug approvals and reimbursements are different processes and there are several challenges we face in making CAR-T therapies widely available in Europe. Should you need more information, please, contact us at info@mpeurope.org
In the description, it is mentioned that CAR-T is recently approved. Can I please ask when this was approved in the US and Europe and where I can find the sources for this? Love this video- Thank you so much!
Hello! thank you for your feedback on this video 😊 there are two CAR-T approved drugs, idecabtagene vicleucel in US and Europe and cilta-cel that was approved by the US Food and Drug Administration (FDA) a couple of days ago. Please, find below some information about these drugs:
• Idecabtagene vicleucel: www.mpeurope.org/2021/03/31/the-u-s-food-and-drug-administration-fda-approves-the-first-anti-bcma-car-t-cell-therapy-for-myeloma-idecabtagene-vicleucel-abecma
• Cilta-cel: www.mpeurope.org/2022/03/02/fda-approves-cilta-cel-for-relapsed-or-refractory-myeloma/
Drug approvals and reimbursements are different processes and there are several challenges we face in making CAR-T therapies widely available in Europe. Should you need more information, please, contact us at info@mpeurope.org